Sodium salicylate acts through direct inhibition of phosphoinositide 3-kinase-like kinases to modulate topoisomerase-mediated DNA damage responses. [electronic resource]
Producer: 20100927Description: 13-20 p. digitalISSN:- 1879-0712
- Anti-Inflammatory Agents, Non-Steroidal -- pharmacology
- Ataxia Telangiectasia Mutated Proteins
- Camptothecin -- pharmacology
- Cell Cycle Proteins -- antagonists & inhibitors
- Cell Death -- drug effects
- Cyclooxygenase 2 Inhibitors -- pharmacology
- DNA Damage -- drug effects
- DNA Topoisomerases -- drug effects
- DNA-Activated Protein Kinase -- antagonists & inhibitors
- DNA-Binding Proteins -- antagonists & inhibitors
- Drug Interactions
- HCT116 Cells
- Humans
- NF-kappa B
- Phosphorylation -- drug effects
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- Replication Protein A -- metabolism
- Signal Transduction -- drug effects
- Sodium Salicylate -- pharmacology
- Tumor Suppressor Protein p53 -- metabolism
- Tumor Suppressor Proteins -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.